The global Artificial Urinary Sphincter Market Size is estimated to be worth US$ 441.7 million in 2022, increasing at a 5.2% CAGR to be worth US$ 769.2 million by 2032. Growth is related to the rising use of lactic acid in end-user industries. Between 2016 and 2021, the lactic acid market increased at a 4.5% CAGR.
Urinary sphincters are two muscles that govern the passage of urine via the urethra in the urinary bladder. These muscles are essential for urine retention and release. These two muscles are known as the external and internal urethral sphincters. When one of the muscles tightens, the urethra closes, preventing pee from passing.
Gain Exclusive Insights into the Rising Market Value of Artificial Urinary Sphincter – Download Our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5285
An Artificial Urinary Sphincter is a silicone rubber device that is chosen for the treatment of urine incontinence. The urinary sphincter is a muscle in your bladder that regulates the flow of pee. An Artificial Urinary Sphincter (AUS) is most typically used in men to control the flow of pee.
It is intended to supplement the natural urinary sphincter’s function of restricting urine flow out of the bladder. An Artificial Urinary Sphincter is a fluid-filled, solid silicone elastomer implant. The Artificial Urinary Sphincter is a popular treatment for male stress urine incontinence because it allows discrete bladder control.
Artificial Urinary Sphincter Market Growth Drivers & Challenges
The Artificial Urinary Sphincter market is primarily driven by a few key factors, including patients’ heavy reliance on time-tested products, increasing advancements in the Artificial Urinary Sphincter, new product launches, and patient preference for safe and effective solutions. In addition, the Artificial Urinary Sphincter market is experiencing considerable expansion as a result of rising healthcare expenditure in emerging countries.
The global ageing population and the rising incidence of urine incontinence are driving the Artificial Urinary Sphincter market. The rising frequency of prostate procedures in males causes urine incontinence, which is one of the driving forces in the Artificial Urinary Sphincter industry.
Despite the fact that the Artificial Urinary Sphincter industry includes multiple end-uses, there are numerous barriers to market expansion. The key factor limiting the growth of the Artificial Urinary Sphincter market is the high treatment costs of the Artificial Urinary Sphincter, which limit its use in the healthcare business.
Artificial Urinary Sphincter Market Report Available At a Discounted Price: https://www.futuremarketinsights.com/request-discount/rep-gb-5285
Artificial Urinary Sphincter Market Regional Insights:
North America was the fastest growing Artificial Urinary Sphincter market, and this trend is likely to continue into the forecast period due to the creation of various treatment facilities and rising healthcare investments. Because of an increase in the use of urinary incontinence devices by patients, North America is expected to account for 35% of the market.
Europe accounts for 26% of the overall worldwide Artificial Urinary Sphincter market, according to Future Market Insights. Growth in Europe is ascribed to expanding allied industries, such as an increase in government spending in the healthcare sector in emerging nations, which is likely to provide new opportunities during the analysis period.
Artificial Urinary Sphincter Market Competition:
Boston Scientific Corporation, RBM – Reinhard Becker Medizinprodukte, ZSI, Zephyr Surgical Implants, Silimed Medical Devices, GT Urological LLC, and others are key players in the global Artificial Urinary Sphincter market.
Because of the large number of participants, the market is extremely competitive. While global players such as Boston Scientific Corporation and RBM – Reinhard Becker Medizinprodukte account for a sizable share of the market, several regional players are also active in key growth regions, particularly Asia Pacific.
- In May 2021- ZSI announced a metoidioplasty with penile implant ZSI 100 D4 was performed by Dr. Madec and Dr. Vidart in Foch hospital, in France. The surgery went very well, and both surgeons are very satisfied with the implants.
- In June 2022- Boston Scientific Corporation announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, (“M.I.Tech”) a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.
Customize Your Report Now: https://www.futuremarketinsights.com/customization-available/rep-gb-5285
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
